* Kyowa Kirin press release [https://ir.kyowakirin.com/en/library/earnings/earnings0/main/0118/teaserItems1/00/linkList/0/link/summary_2025_q3_en.pdf] (OTCPK:KYKOF [https://seekingalpha.com/symbol/KYKOF]): 9M diluted EPS of ¥62.28.
* Revenue of ¥349.45B (-3.7% Y/Y).
MORE ON KYOWA KIRIN CO., LTD.
* Kyowa Kirin Co., Ltd. 2025 Q2 - Results - Earnings Call Presentation [https://seekingalpha.com/article/4807987-kyowa-kirin-co-ltd-2025-q2-results-earnings-call-presentation]
* Kyowa Kirin Co., Ltd. (KYKOF) Q2 2025 Earnings Call Transcript [https://seekingalpha.com/article/4807985-kyowa-kirin-co-ltd-kykof-q2-2025-earnings-call-transcript]
* Amgen, Kyowa Kirin announce long-term Phase 3 data for eczema drug [https://seekingalpha.com/news/4493267-amgen-kyowa-kirin-post-phase-3-data-for-eczema-drug]
* Seeking Alpha’s Quant Rating on Kyowa Kirin Co., Ltd. [https://seekingalpha.com/symbol/KYKOY/ratings/quant-ratings]
* Historical earnings data for Kyowa Kirin Co., Ltd. [https://seekingalpha.com/symbol/KYKOY/earnings]
Kyowa Kirin reports 9M results
Published 1 week ago
Oct 30, 2025 at 4:14 PM
Neutral
Auto